Matches in Nanopublications for { ?s ?p "[The Val158Met polymorphism of COMT is associated with the PSA-progression-free rate of EMP-treated patients in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP206443.RAfysQ6NjtoYPmJ1VqQSD6Sp345we3LtIr9ujZVsPHscA130_assertion description "[The Val158Met polymorphism of COMT is associated with the PSA-progression-free rate of EMP-treated patients in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP206443.RAfysQ6NjtoYPmJ1VqQSD6Sp345we3LtIr9ujZVsPHscA130_provenance.
- NP158947.RArYh48zaYgDJTlIcMAoEYXTDBAbqLJUANOh8Nc1r55bc130_assertion description "[The Val158Met polymorphism of COMT is associated with the PSA-progression-free rate of EMP-treated patients in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP158947.RArYh48zaYgDJTlIcMAoEYXTDBAbqLJUANOh8Nc1r55bc130_provenance.
- NP643631.RA52hxceaGvmGEspaLbJy9hffgCBLraqT5ni08MMaByvc130_assertion description "[The Val158Met polymorphism of COMT is associated with the PSA-progression-free rate of EMP-treated patients in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643631.RA52hxceaGvmGEspaLbJy9hffgCBLraqT5ni08MMaByvc130_provenance.
- assertion description "[The Val158Met polymorphism of COMT is associated with the PSA-progression-free rate of EMP-treated patients in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.